AIDS Research and Therapy | Home page

AIDS Research and Therapy | Home page



AIDS Research and Therapy

Featured review: HIV and tuberculosis

TB is the most common opportunistic infection and cause of mortality among HIV-infected patients, especially in resource-limited countries. This Reviews shows how integration of care for both HIV and TB using a single facility and a single health care provider is a model to deliver integrated therapy for both diseases and manage adverse drug effects efficiently.

Read more

Articles

• Recent
• Most accessed

Recent articles RSS

1. RESEARCH

   Determinants to antiretroviral treatment non-adherence among adult HIV/AIDS patients in northern Ethiopia

   Berhe Beyene Gebrezgabher, Yigzaw Kebede, Melaku Kindie, Desalegn Tetemke, Mebrahtu Abay and Yalemzewod Assefa Gelaw

   Published on: 21 March 2017
2. RESEARCH

   Barriers to uptake of early infant HIV testing in Zambia: the role of intimate partner violence and HIV status disclosure within couples

   Karen M. Hampanda, Abigail M. Nimz and Lisa L. Abuogi

   Published on: 21 March 2017
3. RESEARCH

   Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals

   Jan Weber, Richard M. Gibson, Lenka Sácká, Dmytro Strunin, Jan Hodek, Jitka Weberová, Marcela Pávová, David J. Alouani, Robert Asaad, Benigno Rodriguez, Michael M. Lederman and Miguel E. Quiñones-Mateu

   Published on: 20 March 2017
4. RESEARCH

   Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region)

   Awoke Seyoum, Principal Ndlovu and Zewotir Temesgen

   Published on: 16 March 2017
5. RESEARCH

   Effect of Moringa oleifera Lam. leaf powder on the pharmacokinetics of nevirapine in HIV-infected adults: a one sequence cross-over study

   Tsitsi G. Monera-Penduka, Charles C. Maponga, Alan R. Wolfe, Lubbe Wiesner, Gene D. Morse and Charles F. B. Nhachi

   Published on: 14 March 2017

View all articles

Dr Eric Arts

Eric J Arts is Chair of the Department of Microbiology and Immunology at Western University in London, Canada. His research for the past 16 years described in over 120 publications has focused on HIV-1 fitness, evolution, and virulence in regards to transmission, disease progression, immune escape, drug resistance, and global HIV spread.

Since 1998, he has directed the research laboratories at the Joint Clinical Research Centre, Kampala, Uganda and has collaborated with investigators in Zimbabwe, China, Cameroon, Belgium, UK, France, Brazil, and Argentina. His research has been supported by grants from the NIH (NIAID, NICHD, and NHLBI), from the State of Ohio, Merck, and amfAR. He has served as chair and member of the NIH and CIHR grant panel and has reviewed grants for the many governments around the world.

Dr Mark Boyd

Dr Mark Boyd is Professor and Chair of Medicine at the University of Adelaide based at the Lyell McEwin Hospital. He is the current President of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM).

Dr Boyd has published the SECOND-LINE and Encore1 studies, the results of which have been incorporated into the most recent (2016) WHO integrated guidelines for the management of HIV-infection.

In 2014, Dr Boyd was awarded the prestigious Frank Fenner Prize for Advanced Research in Infectious Diseases by the Australasian Society for Infectious Diseases (ASID). Dr Boyd has attracted over 20 million AUD in research funding from government, industry and non-government organisational sources. He collaborates with colleagues in HIV clinical research worldwide, particularly in the Asia-Pacific region.